Virus Like Particles as Immunogens and Universal Nanocarriers

Area of Science:

• Biomedical Research
• Nanotechnology
• Vaccinology

Background:

• Virus-like particles (VLPs) are self-assembling protein structures that mimic the morphology of native viruses but lack genomic material.
• This non-infectious and non-replicative nature makes VLPs a safe platform for various biomedical applications.
• VLPs have emerged as crucial tools in research and medicine over the past two decades.

Purpose of the Study:

• To review the synthesis and manipulation strategies for virus-like particles (VLPs).
• To discuss the diverse applications of VLPs in biomedical research and medicine.
• To highlight VLPs as versatile nanovectors for therapeutic delivery and vaccine development.

Main Methods:

• Review of existing literature on VLP synthesis and applications.
• Analysis of VLP properties, including cell penetration and antigenicity.
• Discussion of VLP flexibility in composition and expression systems.

Main Results:

• VLPs serve as safe and effective alternatives to traditional vaccines by mimicking viral antigens.
• VLPs demonstrate efficient cellular transduction, enabling the delivery of nucleic acids, proteins, and conjugated compounds.
• The adaptable nature of VLPs allows for customization in their composition and production using various expression systems.

Conclusions:

• Virus-like particles (VLPs) represent a significant advancement in biomedical science, offering a safe and versatile platform.
• Their applications span vaccine development, targeted drug/gene delivery, and fundamental research.
• Continued exploration of VLP synthesis and manipulation will further expand their therapeutic and diagnostic potential.